Prospective study reveals contralateral nigrosome-1 neuromelanin loss and iron accumulation in early Parkinson's disease, highlighting coupled asymmetric neurodegeneration.
BACKGROUND: Parkinson's disease (PD) often presents with lateralized motor symptoms at onset, reflecting asymmetric degeneration of the substantia nigra (SN). Neuromelanin (NM) loss and iron accumulation are hallmarks of SN pathology in PD, but their spatial distribution and interrelationship in PD patients with right-sided (PDR) or left-sided (PDL) motor symptom onset remain unclear. PURPOSE: To investigate the spatial vulnerability and interrelationship of NM and iron in the SN among PDR, PDL, and healthy controls (HCs) using MRI. STUDY TYPE: Prospective. POPULATION: 56 early-stage PD patients (28 PDR: 55.93 ± 7.41 years, 16 female/12 male; 28 PDL: 59.04 ± 10.44 years, 13 female/15 male) and 30 age- and gender-matched HCs (57.47 ± 4.07 years, 17 female/13 male). FIELD STRENGTH/SEQUENCE: 3-T, T1-weighted Fast Spoiled Gradient Recalled (FSPGR) and gradient recalled echo (GRE) for quantitative susceptibility mapping (QSM). ASSESSMENT: Voxel-wise group comparisons of NM and iron were performed, and overlapping clusters with co-localized NM loss and iron deposition were identified. Mean cluster values were extracted for subsequent group comparison and NM-iron relationship modeling. STATISTICAL TESTS: Welch's analysis of variance (ANOVA), Chi-squared test, Mann-Whitney U, voxel-wise analysis of covariance (ANCOVA), bidirectional mediation, partial correlation. RESULTS: Cluster 1 (PDR vs. HC) in left nigrosome-1 showed concurrent NM reduction (1.14 ± 0.09 vs. 1.30 ± 0.06) and iron increase (0.14 ± 0.06 vs. 0.08 ± 0.04 ppm); Cluster 2 (PDL vs. HC) in right nigrosome-1 also showed concurrent NM reduction (1.15 ± 0.06 vs. 1.28 ± 0.07) and iron increase (0.16 ± 0.05 vs. 0.10 ± 0.04 ppm). Bidirectional mediation revealed significant NM-iron direct and indirect effects in PDR and PDL (vs. HCs). DATA CONCLUSION: This QSM-based study demonstrates contralateral nigrosome-1 as the vulnerable region with concurrent NM loss and iron accumulation and exhibits reciprocal mediation effects between NM and iron in early-stage PD. TECHNICAL EFFICACY: Stage 2.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: